Go
View All
Conversion from IR form to ER form- carvedilol(adult)
2-16 yrs- methotrexate [Injectable](peds)
2-16 yrs - methotrexate [Oral](peds)
2-17 yrs- lamivudine, 3TC(peds)
21-Day Regimen- ethinyl estradiol/norgestimate (triphasic OCP)(adult)
21-Day Regimen- ethinyl estradiol/norgestimate (triphasic OCP)(peds)
24h extended-release form- diltiazem [Oral](adult)
2-5 yrs: Rectal Suppositories (SUPP: 80.7%, 82.5%, 1, 1.2 g; SUPP LIQ: 2.3 g)- glycerin [Rectal](peds)
28-Day Regimen- ethinyl estradiol/norgestimate (triphasic OCP)(adult)
28-Day Regimen- ethinyl estradiol/norgestimate (triphasic OCP)(peds)
2months-12yrs- nystatin/triamcinolone [Topical](peds)
2nd/3rd degree burns (Not FDA approved)- silver sulfadiazine [Topical](peds)
2nd/3rd degree burns- silver sulfadiazine [Topical](adult)
2nd Line therapy (Patients already on Sulfonylurea and/or Metformin)- glyburide/metformin(adult)
Conversion from oral to IV sotalol- sotalol [IV](adult)
Conversion from transdermal fentanyl to extended release hydromorphone- hydromorphone [Oral](adult)
Conversion of atrial fibrillation/flutter to sinus rhythm- quinidine [Oral](adult)
Conversion of atrial fibrillation or atrial flutter- ibutilide [IV](adult)
Conversion to Monotherapy (>=10 yrs)- valproate [IV](peds)
Conversion to Monotherapy (>=10 yrs)- valproic acid [Oral](peds)
Conversion to Monotherapy- divalproex sodium(adult)
Conversion to Monotherapy- divalproex sodium(peds)
Conversion to Monotherapy in seizure disorder- felbamate(adult)
Conversion to Monotherapy in seizure disorder- felbamate(peds)
Conversion to Monotherapy- valproate [IV](adult)
Conversion to Monotherapy- valproic acid [Oral](adult)
Converting from or to parenteral anticoagulants- dabigatran(adult)
3-12 months and >5 kg- lidocaine/prilocaine [Topical](peds)
3-12 yrs; 15-40 kgs- haloperidol [Oral](peds)
3-Day Dose- fosaprepitant [IV](adult)
Displaying items 421 - 450 of 11661